chalcone has been researched along with Cancer of Prostate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Iwai, A; Kim, YS; Kumar, V; Lee, S; Malhotra, SV; Neckers, L; Trepel, JB | 1 |
| Aoyama, S; Iwamoto, H; Izumi, K; Kadomoto, S; Kadono, Y; Kamijima, T; Kano, H; Mizokami, A; Naito, R; Nakagawa, R; Nakagawa-Goto, K; Nakata, H; Saito, Y; Shimada, T; Toriumi, R; Yaegashi, H | 1 |
| Gao, M; Han, W; Wang, K; Wang, X; Wang, Z; Xu, X; Zhang, N; Zhang, W | 1 |
| Chen, C; Gao, X; Huang, J; Li, B; Li, X; Liu, E; Liu, R; Miao, L; Shao, R; Wang, T; Wang, Y; Zhai, Y; Zhang, H; Zhu, Y | 1 |
| Barette, C; Champavier, Y; Fagnère, C; Gamond, A; Laurent, A; Liagre, B; Martin, F; Pinon, A; Pouget, C; Rioux, B; Sol, V | 1 |
| Anhê, GF; Carvalho, JE; de Araujo, TM; Ehrenfried, CA; Gilioli, R; Lopez, BG; Pascoal, AC; Pascoal, VD; Ruiz, AL; Salvador, MJ; Stefanello, ME | 1 |
| Bedi, PM; Jain, S; Kumar, D; Kumar, S; Malik, F; Nepali, K | 1 |
| Ding, L; Li, X; Lilly, MB; Liu, HM; Mercola, D; Yokoyama, NN; Zhang, S; Zi, X | 1 |
| Jung, JC; Jung, YS; Lee, YH; Oh, S; Yun, J | 1 |
| Cong, H; Deb Majumdar, I; Devanabanda, A; Fox, B; Porco, JA; Schwartzman, J; Weber, HC | 1 |
| Ashwini, C; Chandra, R; Gawali, BB; Gnana Deepthi, E; Lakshma Nayak, V; Nagaraju, M; Ramakrishna, S; Vishnuvardhan, MV | 1 |
| Kapoor, S | 1 |
| Baba, M; Kanazawa, M; Kawauchi, A; Miki, T; Mizutani, Y; Nishino, H; Okuyama, T; Sakai, T; Satomi, Y; Ukimura, O | 1 |
| Darzynkiewicz, Z; Fu, Y; Guo, J; Hsieh, TC; Kunicki, J; Lee, MY; Wu, JM | 1 |
| Cho, HJ; Choi, HJ; Chung, WY; Jung, JI; Kim, EJ; Lim, SS; Park, JH; Park, KK; Shin, HK | 1 |
15 other study(ies) available for chalcone and Cancer of Prostate
| Article | Year |
|---|---|
Methoxychalcone inhibitors of androgen receptor translocation and function.
Topics: Androgen Antagonists; Cell Line, Tumor; Chalcones; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Male; Prostatic Neoplasms; Protein Transport; Receptors, Androgen | 2012 |
Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells.
Topics: Androgen Antagonists; Androgens; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Humans; Male; Paclitaxel; Prostatic Neoplasms; Receptors, Androgen; Taxoids | 2023 |
Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway.
Topics: Apoptosis; Binding Sites; Chalcone; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Glutathione; Glutathione S-Transferase pi; Glutathione Synthase; Humans; Male; Metabolic Networks and Pathways; Metabolomics; Molecular Docking Simulation; PC-3 Cells; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Tubulin | 2020 |
Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
Topics: Androgen Receptor Antagonists; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chalcone; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Male; Mice; Mice, Nude; PC-3 Cells; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays | 2021 |
Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Chalcone; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Models, Molecular; Molecular Structure; Polyamines; Prostatic Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Antiproliferative activity and induction of apoptosis in PC-3 cells by the chalcone cardamonin from Campomanesia adamantium (Myrtaceae) in a bioactivity-guided study.
Topics: Apoptosis; Brazil; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Humans; Male; Myrtaceae; Plant Extracts; Prostatic Neoplasms | 2014 |
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chalcone; HCT116 Cells; Humans; Lung Neoplasms; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms; Pyrimidinones | 2015 |
Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Chalcone; Cullin Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Humans; Male; Mice, Inbred C57BL; Mice, Transgenic; Molecular Docking Simulation; NEDD8 Protein; Phenotype; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Binding; Protein Processing, Post-Translational; Proteolysis; Retinoblastoma Protein; S-Phase Kinase-Associated Proteins; Time Factors; Transfection; Ubiquitin-Conjugating Enzymes; Ubiquitination; Ubiquitins | 2015 |
Anti-tumor activity of benzylideneacetophenone derivatives via proteasomal inhibition in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chalcone; Dimerization; Humans; Male; Propiophenones; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors | 2016 |
Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro.
Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cathepsins; Cell Cycle; Cell Line, Tumor; Chalcone; Chalcones; Cyclohexanes; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Male; Prostatic Neoplasms | 2011 |
Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chalcone; Drug Screening Assays, Antitumor; Humans; Male; Mice; Prostatic Neoplasms; Structure-Activity Relationship | 2012 |
Letter to the Editor on "Synthetic cyclohexenyl chalcone natural products possess cytotoxic activities against prostate cancer cells and inhibit cysteine cathepsins in vitro".
Topics: Antineoplastic Agents; Biological Products; Cathepsins; Chalcone; Cyclohexanes; Cysteine Proteinase Inhibitors; Humans; Male; Prostatic Neoplasms | 2012 |
Isoliquiritigenin inhibits the growth of prostate cancer.
Topics: CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell Division; Chalcone; Chalcones; Dose-Response Relationship, Drug; Flavonoids; Glycyrrhiza; Humans; Male; Plant Extracts; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Messenger; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured | 2003 |
Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cell Size; Chalcone; Chalcones; Flavonoids; G1 Phase; G2 Phase; Glycyrrhiza; Humans; Male; Neoplasm Proteins; Plant Roots; Prostatic Neoplasms | 2004 |
Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells.
Topics: Animals; Apoptosis; Blotting, Western; Caspases; Cell Division; Cell Line, Tumor; Chalcone; Chalcones; Cytochromes c; Enzyme Activation; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Male; Membrane Glycoproteins; Membrane Potentials; Mitochondrial Membranes; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rats; Tumor Necrosis Factors | 2006 |